Skip to main content

Peer Review reports

From: A double blinded placebo controlled comparative clinical trial to evaluate the effectiveness of Siddha medicines, Kaba Sura Kudineer (KSK) & Nilavembu Kudineer (NVK) along with standard Allopathy treatment in the management of symptomatic COVID 19 patients - a structured summary of a study protocol for a randomized controlled trial

Original Submission
8 Jan 2021 Submitted Original manuscript
11 Jan 2021 Reviewed Reviewer Report - Kirsty Loudon
Resubmission - Version 2
Submitted Manuscript version 2
11 Jan 2021 Editorially accepted
11 Feb 2021 Article published 10.1186/s13063-021-05041-x

You can find further information about peer review here.

Back to article page